Topics

Glaukos achieves pipeline milestone with completion of patient enrollment in US IDE trial for iStent infinite

12:04 EDT 11 Oct 2019 | Compelo Medical Devices

Glaukos, an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced the completion of patient enrollment

The post Glaukos achieves pipeline milestone with completion of patient enrollment in US IDE trial for iStent infinite appeared first on NS Medical Devices.

Original Article: Glaukos achieves pipeline milestone with completion of patient enrollment in US IDE trial for iStent infinite

NEXT ARTICLE

More From BioPortfolio on "Glaukos achieves pipeline milestone with completion of patient enrollment in US IDE trial for iStent infinite"

Quick Search